VERTEX PHARMACEUTICALS INC / MA (VRTX)
Clinical trial NCT05791201 updates: 1. completion date: 2026-05-29 → 2027-03-12 2. primary completion date: 2026-05-29 → 2027-03-12
Clinical trial NCT05791201 updates: 1. completion date: 2026-05-29 → 2027-03-12 2. primary completion date: 2026-05-29 → 2027-03-12
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical